|
1
|
Hunninghake GW and Kalica AR: Approaches
to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med.
151:915–918. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Munger JS, Huang X, Kawakatsu H, Griffiths
MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, et
al: The integrin alpha v beta 6 binds and activates latent TGF beta
1: A mechanism for regulating pulmonary inflammation and fibrosis.
Cell. 96:319–328. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haider Y, Malizia AP, Keating DT, Birch M,
Tomlinson A, Martin G, Ferguson MW, Doran PP and Egan JJ: Host
predisposition by endogenous transforming growth factor-beta1
overexpression promotes pulmonary fibrosis following bleomycin
injury. J Inflamm (Lond). 4:182007. View Article : Google Scholar
|
|
4
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dworniczak S, Ziora D, Kapral M, Mazurek
U, Niepsuj G, Rauer R, Wilczok T and Kozielski J: Human
cytomegalovirus DNA level in patients with idiopathic pulmonary
fibrosis. J Physiol Pharmacol. 55(Suppl 3): S67–S75. 2004.
|
|
6
|
Michelson S, Alcami J, Kim SJ, Danielpour
D, Bachelerie F, Picard L, Bessia C, Paya C and Virelizier JL:
Human cytomegalovirus infection induces transcription and secretion
of transforming growth factor beta 1. J Virol. 68:5730–5737.
1994.PubMed/NCBI
|
|
7
|
Desmouliére A, Darby IA and Gabbiani G:
Normal and pathologic soft tissue remodeling: Role of the
myofibroblast, with special emphasis on liver and kidney fibrosis.
Lab Invest. 83:1689–1707. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akbari A, Ghahremani MH, Mobini GR,
Abastabar M, Akhtari J, Bolhassani M and Heidari M: Down-regulation
of miR-135b in colon adenocarcinoma induced by a TGF-β receptor I
kinase inhibitor (SD-208). Iran J Basic Med Sci. 18:856–861.
2015.PubMed/NCBI
|
|
9
|
Jennings JC, Mohan S, Linkhart TA,
Widstrom R and Baylink DJ: Comparison of the biological actions of
TGF beta-1 and TGF beta-2: Differential activity in endothelial
cells. J Cell Physiol. 137:167–172. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sime PJ and O'Reilly KM: Fibrosis of the
lung and other tissues: New concepts in pathogenesis and treatment.
Clin Immunol. 99:308–319. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kasai H, Allen JT, Mason RM, Kamimura T
and Zhang Z: TGF-beta1 induces human alveolar epithelial to
mesenchymal cell transition (EMT). Respir Res. 6:562005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu YD, Hua J, Mui A, O'Connor R,
Grotendorst G and Khalil N: Release of biologically active
TGF-beta1 by alveolar epithelial cells results in pulmonary
fibrosis. Am J Physiol Lung Cell Mol Physiol. 285:L527–L539. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y: Epithelial to mesenchymal
transition in renal fibrogenesis: Pathologic significance,
molecular mechanism, and therapeutic intervention. J Am Soc
Nephrol. 15:1–12. 2004. View Article : Google Scholar
|
|
14
|
Kossmann T, Morganti-Kossmann MC,
Orenstein JM, Britt WJ, Wahl SM and Smith PD: Cytomegalovirus
production by infected astrocytes correlates with transforming
growth factor-beta release. J Infect Dis. 187:534–541. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kwon YJ, Kim DJ, Kim JH, Park CG, Cha CY
and Hwang ES: Human cytomegalovirus (HCMV) infection in
osteosarcoma cell line suppresses GM-CSF production by induction of
TGF-beta. Microbiol Immunol. 48:195–199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koli K, Saharinen J, Hyytiäinen M,
Penttinen C and Keski-Oja J: Latency, activation, and binding
proteins of TGF-beta. Microsc Res Tech. 52:354–362. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Annes JP, Munger JS and Rifkin DB: Making
sense of latent TGFbeta activation. J Cell Sci. 116:217–224. 2003.
View Article : Google Scholar
|
